Teva Pharmaceutical Industries Limited

Common Stock · USD · NYSE

TEVAT212

Price

$34.3

-2.40%

Cap

—

Earnings

—

30d Trend

+8.7%

0LER

Loading chart data...

0 days · % change from startPowered by Brain47

BRAIN47 SIGNAL

STRONG

Risk Level50

Quality66

Momentum85

Technical58

Fundamentals50

Raw weighted: 68×Macro 0.99 (−1%)=67

RISK

50/100

90d Volatility

34.9%Moderate

ATR %

2.8%Normal

Max Drawdown (1Y)

-21.8%Normal

QUALITY

66/100

ROE (avg)

17.8%Good

Piotroski F-Score

6/9Average

Margin Stability

CV 2.9%Very stable

Accruals

-0.6%Cash earnings

Interest Coverage

2.4xTight

MOMENTUM

85/100

12-1M Momentum

+81.1%Strong uptrend

6-1M Momentum

+19.2%Positive

1M Return

+9.3%Strong recent gains

TECHNICAL

58/100

RSI (14)

55.2Neutral

Price vs SMA200

+25.7%Bullish trend

MACD

-0.25Bearish momentum

Bollinger Band

32%Mid-range

SMA Cross

Death CrossDeath Cross

Trend Quality (KER)

0.290Noisy/choppy

FUNDAMENTALS

50/100

Macro: neutral (×0.99) - Fear/Greed: 65 (Greed) - Data: 80%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months47

3-12 months ★73

1-5+ years60

6-9 month momentum thesis — strong trend with confirmation

BRAIN47'S ASSESSMENT

I rate Teva Pharmaceutical Industries Limited at 67/100 — a STRONG reading on the Brain47 Signal. The strongest factor is momentum at 85/100. I classify this as a growth position with the strongest thesis on a medium-term horizon.

DETAILED ANALYSIS

6-9 month momentum thesis — strong trend with confirmation. Momentum (85) and Quality (66) are the primary strengths. I classify this as a growth position — strong momentum combined with growth potential points to capital appreciation.

growthScore: 67/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.